The Design and Analysis of Half-Life and Recovery Studies for Factor VIII and Factor IX

• References

• 1 Allain JP, Verroust F, Soulier JP. In vitro and in vivo characterization of Factor VIII preparations. Vox Sang 1980; 38: 68-80
• 2 Hellstern P, Kiehl R, Miyashita C, Schwerdt H, von Blohn G, Köhler M, Büttner M, Wenzel E. Factor VIII:C (FVIII:C) recovery and half-life after infusion of steam-treated high purity Factor VIII concentrate in severe hemophilia A - comparison of one-stage assay, two-stage assay and a chromogenic substrate assay. Thromb Haemostas 1986; 56: 353-9
• 3 Brettler DB, Forsberg AG, Levine PH, Petillo J, Lamon K, Sullivan JL. Factor VIII: C concentrate purified from plasma using monoclonal antibodies: human studies. Blood 1989; 73: 1859-63
• 4 Messori A, Longo G, Matucci M, Morfini M, Rossi-Ferrini P. Clinical pharmacokinetics of factor VIII in patients with classic hemophilia. Clin Pharmacokinet 1987; 13: 365-80
• 5 Messori A, Longo G, Morfini M, Cinotti S, Filimberti E, Giustarini G, Rossi-Ferrini P. Multi-variate analysis of factors governing the pharmacokinetics of exogenous Factor VIII in hemophiliacs. Eur J Clin Pharmacol 1988; 35: 663-8
• 6 Dixon WJ, Massey FJ. Introduction to Statistical Analysis. 5th ed.. McGraw-Hill Book Co., New York: 1983. p 569
• 7 Blombôck M, Cinotti S, Longo G, Messori A, Morfini M, Schimpf K. One stage, two stage and chromogenic Factor VIII:C assays: a multicenter study. (Abstract). International Congress of the World Federation of Hemophilia, Washington: 1990
• 8 Finney DJ. Statistical Method in Biological Assay. 3rd edition.. Macmillan Publishing Co., New York: 1978. pp 133-47
• 9 Heldebrant C, Kleszynski R, Short M, Aronson D, Brown L, Jacoby G, Lee M, Thomas D, Barrowcliffe T, Howell I, Johnson RC. Assay of AHF concentrates and standards: failure to eliminate variability with a monographed assay. Thromb Res 1983; 30: 337-46
• 10 Liu SL, Gomperts E, Garanchon L, Foster V, Andrade J, Courter S, Kingdon H, Griffith M. One state clotting assay of recombinant and immunoaffinity purified FVIII: the effect of von Willebrand factor. XIIth Congress of the International Society for Thrombosis and Haemostasis, Tokyo 1989. Thromb Haemostas 1989; 62: 209 (Abstr 638)
• 11 Morfini M, Messori A, Longo G, White GC, Gomperts E, Mannucci PM. Pharmacokinetics of recombinant FVIII compared with monoclonal antibody purified, plasma-derived FVIII. XIIth Congress of the International Society for Thrombosis and Haemostasis, Tokyo 1989. Thromb Haemostas 1989; 62: 198 (Abstr 598)
• 12 Matucci M, Messori A, Donati-Cosi G, Longo G, Vannini S, Morfini M, Tendi E, Rossi Ferrini P. Kinetic evaluation of four Factor VIII concentrates by model independent methods. Scand J Haematol 1985; 34: 22-8
• 13 Longo G, Matucci M, Messori A, Morfini M, Rossi-Ferrini P. Pharmacokinetics of a new heat-treated concentrate of Factor VIII estimated by model-independent methods. Thromb Res 1986; 42: 471-6
• 14 Clark B, Smith DA. An Introduction to Pharmacokinetics. 2nd edition.. Blackwell Scientific Publications, Oxford: pp 26-33
• 15 Messori A, Donati-Cori G, Tendi E. Iterative least-squares fitting programs in pharmacokinetics for a programmable hand-held calculator. Am J Hosp Pharm 1983; 40: 1673-84
• 16 Ruffo S, Messori A, Donati-Cori G, Tendi E, Rosselli P, Varini C. Calculator programs for weighted least-squares nonlinear regression analysis in pharmacokinetics. Am J Hosp Pharm 1985; 42: 628
• 17 Lee ML, Poon W-Y, Kingdon HS. A two-phase linear regression model for biological half-life data. J Lab Clin Med 1990; 115: 745-8
• 18 Boxenbaum HG, Riegelman S, Elashoff RM. Statistical estimation in pharmacokinetics. J Pharmacokinet Biopharm 1974; 2: 123-42
• 19 Berkow R. (ed) The Merck Manual of Diagnosis and Therapy. 18th ed.. Merck Sharp & Dohme Research Laboratories, Rahway, NJ: 1987. p 2413
• 20 Lee ML, Kingdon HS. A note on the calculation of recovery for factor VIII infusions. (Unpublished manuscript)